Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD ▲ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Durect Corp. | -8.040% | - | - | - | - | - | - |
| Adamas Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
| Applied Therapeutics Inc | 2.950% | - | - | - | - | - | - |
| Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |
| Gritstone Oncology Inc | 13.680% | 16.156% | -19.102% | -60.022% | -52.018% | -88.090% | - |
| Acadia Pharmaceuticals | 1.450% | - | -7.081% | -18.672% | -45.018% | -6.998% | -32.549% |
| NanoVibronix Inc. | -8.090% | -8.759% | -23.313% | -80.590% | -41.038% | - | - |
| Coherus Bioscien. | 4.310% | 10.673% | -4.405% | -67.960% | -30.757% | -83.425% | -85.702% |
| Biocryst Pharmaceuticals | -1.220% | 6.102% | -5.720% | -45.083% | -25.533% | -55.650% | -39.530% |
| Sangamo Therapeutics Inc. | 3.900% | 5.702% | -8.695% | -57.187% | -10.711% | -94.675% | -95.005% |
| Exelixis Inc. | -6.500% | -6.016% | -4.801% | 18.642% | -5.759% | 0.438% | 14.049% |
| Intra-Cellular Therapies Inc. | -3.030% | -7.246% | 2.400% | 13.879% | -1.840% | 133.747% | 408.744% |
| Madrigal Pharmaceuticals inc. | 5.910% | 18.008% | -5.828% | -22.689% | 0.899% | 87.105% | 129.207% |
| Thermogenesis Holdings Inc. | -1.610% | 1.667% | -12.857% | -69.802% | 7.018% | -99.378% | -99.409% |
| Akebia Therapeutics Inc. | 5.260% | 2.324% | -6.856% | 59.625% | 8.959% | -51.629% | - |
| Twist Bioscience Corp | 27.860% | 29.861% | 24.253% | 244.464% | 10.799% | -61.749% | - |
| Anika Therapeutics | 1.650% | 3.361% | 2.500% | 5.128% | 20.588% | -26.347% | -20.427% |
| Blueprint Medicines Corp | 0.800% | 14.496% | 16.835% | 111.745% | 20.630% | 24.931% | - |
| Fibrogen Inc. | -1.670% | 11.469% | -22.033% | -93.063% | 22.616% | -94.225% | - |
| AnaptysBio Inc | 8.770% | 27.179% | 31.217% | 29.167% | 27.835% | 27.835% | - |
| Evolus Inc | 10.280% | 12.381% | -5.600% | 60.544% | 30.387% | 60.544% | - |
| X4 Pharmaceuticals, Inc. | 5.830% | -1.469% | -21.219% | -18.712% | 37.564% | - | - |
| Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
| Agios Pharmaceuticals Inc. | 3.380% | 3.378% | 18.605% | 47.115% | 48.544% | -33.159% | -37.056% |
| Heron Therapeutics Inc. | 4.300% | 5.493% | 2.196% | 19.802% | 54.140% | -83.177% | - |
| Deciphera Pharmaceuticals | - | 75.940% | 68.345% | 81.960% | 59.238% | -37.766% | - |
| Actinium Pharmaceuticals Inc. | 1.290% | 28.594% | 1.100% | 0.303% | 83.075% | 29.297% | - |
| Geron Corp. | -1.390% | 3.081% | 23.251% | 51.202% | 85.315% | 206.471% | 131.556% |
| Cardiff Oncology Inc. | -20.910% | -14.417% | -33.503% | 93.424% | 148.100% | -58.931% | -6.714% |